CU22928A3 - Procedimiento para la preparación de pirazolo (4,3-d) pirimidin-7-onas y sus intermedios - Google Patents

Procedimiento para la preparación de pirazolo (4,3-d) pirimidin-7-onas y sus intermedios

Info

Publication number
CU22928A3
CU22928A3 CU1999142A CU1999142A CU22928A3 CU 22928 A3 CU22928 A3 CU 22928A3 CU 1999142 A CU1999142 A CU 1999142A CU 1999142 A CU1999142 A CU 1999142A CU 22928 A3 CU22928 A3 CU 22928A3
Authority
CU
Cuba
Prior art keywords
preparation
pirazolo
pirimidin
onas
intermediates
Prior art date
Application number
CU1999142A
Other languages
English (en)
Inventor
Philip Charles Levett
Peter James Dunn
Original Assignee
Pfizer Ireland Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10840421&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CU22928(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Ireland Pharmaceuticals filed Critical Pfizer Ireland Pharmaceuticals
Publication of CU22928A3 publication Critical patent/CU22928A3/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Se proporciona un procedimiento para la preparación de un compuesto de fórmulas (IA) ( sildenafil/Viagra TM) y (IB) ESPACIO PARA FÓRMULAS. que comprende hacer reaccionar un compuesto de fórmula (IIA) y (IIB), respectivamente, en presecia de OR, siendo R, en el caso de la formación del compuesto (IA), CH2CH3 y, siendo R, en el caso de la formación del compuesto (IB), CH2CH2CH3, y siendo X un grupo saliente. ESPACIO PARA FÓRMULAS.
CU1999142A 1998-10-12 1999-09-22 Procedimiento para la preparación de pirazolo (4,3-d) pirimidin-7-onas y sus intermedios CU22928A3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9822238.3A GB9822238D0 (en) 1998-10-12 1998-10-12 Process for preparation of pyrazolo[4,3-D]pyrimidin-7-ones and intermediates thereof

Publications (1)

Publication Number Publication Date
CU22928A3 true CU22928A3 (es) 2004-02-20

Family

ID=10840421

Family Applications (1)

Application Number Title Priority Date Filing Date
CU1999142A CU22928A3 (es) 1998-10-12 1999-09-22 Procedimiento para la preparación de pirazolo (4,3-d) pirimidin-7-onas y sus intermedios

Country Status (49)

Country Link
US (3) US6207829B1 (es)
EP (1) EP0994115B1 (es)
JP (1) JP3721021B2 (es)
KR (1) KR100380954B1 (es)
CN (2) CN1207295C (es)
AP (1) AP1233A (es)
AR (1) AR019244A1 (es)
AT (1) ATE290003T1 (es)
AU (1) AU756463B2 (es)
BG (1) BG63205B1 (es)
BR (1) BR9905092A (es)
CA (1) CA2285733C (es)
CO (1) CO5150214A1 (es)
CR (1) CR6118A (es)
CU (1) CU22928A3 (es)
CZ (1) CZ296816B6 (es)
DE (1) DE69923906T2 (es)
DK (1) DK0994115T3 (es)
DZ (1) DZ2912A1 (es)
EA (1) EA003774B1 (es)
EE (1) EE04192B1 (es)
EG (1) EG22630A (es)
ES (1) ES2237049T3 (es)
GB (1) GB9822238D0 (es)
GE (1) GEP20022700B (es)
GT (1) GT199900172A (es)
HK (1) HK1027559A1 (es)
HR (1) HRP990318B1 (es)
HU (1) HU226162B1 (es)
ID (1) ID23351A (es)
IL (11) IL132273A (es)
IS (1) IS1951B (es)
MA (1) MA25007A1 (es)
MY (1) MY124620A (es)
NO (1) NO313700B1 (es)
OA (1) OA11165A (es)
PE (1) PE20001086A1 (es)
PL (1) PL198150B1 (es)
PT (1) PT994115E (es)
RS (1) RS49762B (es)
SG (1) SG118060A1 (es)
SI (1) SI0994115T1 (es)
SK (1) SK285215B6 (es)
TN (1) TNSN99189A1 (es)
TR (1) TR199902541A2 (es)
TW (1) TW589314B (es)
UA (1) UA66787C2 (es)
UY (1) UY25750A1 (es)
ZA (1) ZA996412B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5204800A (en) * 1999-06-21 2001-01-09 Biochemical Pharmaceutical Factory of Zhuhai Sez, The Process for preparing sildenafil, and troche which comprises sildenafil and apomorphine
AU6259701A (en) * 2000-06-22 2002-01-02 Dunn Peter James Process for the preparation of pyrazolopyrimidinones
US6667398B2 (en) 2000-06-22 2003-12-23 Pfizer Inc Process for the preparation of pyrazolopyrimidinones
EP1176142A1 (en) * 2000-07-28 2002-01-30 Pfizer Inc. Process for the preparation of pyrazoles
US6407259B1 (en) 2000-07-28 2002-06-18 Pfizer Inc. Process for the preparation of pyrazoles
YU51701A (sh) * 2000-07-28 2003-12-31 Pfizer Inc. Postupak za dobijanje jedinjenja pirazola/4,3-d/ pirimidin-7-ona i njihovih derivata
PE20020394A1 (es) 2000-08-18 2002-06-21 Agouron Pharma Compuestos de pirazol y composiciones farmaceuticas que los contienen, que modulan y/o inhiben la actividad de erab/hadh2
ATE455758T1 (de) 2001-12-20 2010-02-15 Merck Serono Sa Pyrrolidin-derivatie als prostaglandin- modulatoren
WO2003059258A2 (en) * 2001-12-21 2003-07-24 Cytokinetics, Inc. Compositions and methods for treating heart failure
SI1509525T1 (sl) 2002-05-31 2006-12-31 Schering Corp Postopek priprave inhibitorjev ksantinske fosfodiesteraze V in njihovih prekurzorjev
WO2004072079A1 (en) * 2003-02-11 2004-08-26 Pfizer Limited Hydrated and anhydrous sildenafil hemi-citrate compound
ES2378620T3 (es) * 2003-03-27 2012-04-16 Cytokinetics, Inc. Sulfonamidas para el tratamiento de insuficiencia cardiaca congestiva, sus composiciones y usos.
CN100360531C (zh) * 2003-12-18 2008-01-09 中国人民解放军军事医学科学院放射与辐射医学研究所 用于预防或治疗阳萎和性冷淡的新吡唑并嘧啶类化合物
US20070010525A1 (en) * 2005-06-27 2007-01-11 Meyer Jackson Method and compositions for modulating neuropeptide hormone secretion
NL2000291C2 (nl) * 2005-11-10 2009-02-17 Pfizer Prod Inc 1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H- pyrazool(4,3-d)pyrimidine-5-yl)piperidine-4-carbonzuur en zouten daarvan.
EP2024369A4 (en) * 2006-06-05 2010-10-27 Matrix Lab Ltd NEW PROCESS FOR THE PREPARATION OF SILDENAFIL CITRATE
CZ308056B6 (cs) * 2015-07-20 2019-11-27 Ustav Experimentalni Botaniky Av Cr V V I 5-Substituované-7-[4-(substituované)benzyl]amino-3-isopropylpyrazolo[4,3-d]pyrimidiny, jejich použití jako antirevmatika, a farmaceutické přípravky
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil
CN107759603B (zh) * 2016-08-18 2020-09-01 四川科伦药物研究院有限公司 一种杂环化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992441A (en) * 1972-12-26 1976-11-16 Pfizer Inc. Sulfamylbenzoic acids
GB9013750D0 (en) * 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
GB9612514D0 (en) * 1996-06-14 1996-08-14 Pfizer Ltd Novel process
SK285991B6 (sk) * 1997-04-25 2008-01-07 Pfizer Inc. Pyrazolopyrimidinóny, spôsob a medziprodukty na ich výrobu, ich použitie a farmaceutické a veterinárne kompozície na ich báze

Also Published As

Publication number Publication date
PL198150B1 (pl) 2008-05-30
NO994943L (no) 2000-04-13
GT199900172A (es) 2001-03-28
US6207829B1 (en) 2001-03-27
SK138599A3 (en) 2000-05-16
IL152928A0 (en) 2003-06-24
CN1255497A (zh) 2000-06-07
OA11165A (en) 2003-04-22
ZA996412B (en) 2001-04-11
HRP990318B1 (en) 2004-06-30
HUP9903469A2 (hu) 2000-08-28
SG118060A1 (en) 2006-01-27
ID23351A (id) 2000-04-13
IL152926A0 (en) 2003-06-24
IL152923A (en) 2004-02-08
DZ2912A1 (fr) 2004-03-01
HU9903469D0 (en) 1999-12-28
IL152927A (en) 2004-06-01
EP0994115A3 (en) 2000-05-24
US20010009962A1 (en) 2001-07-26
IL132273A0 (en) 2001-03-19
DE69923906D1 (de) 2005-04-07
TNSN99189A1 (fr) 2005-11-10
EA003774B1 (ru) 2003-08-28
AU756463B2 (en) 2003-01-16
IS5209A (is) 2000-04-13
EP0994115B1 (en) 2005-03-02
EA199900822A2 (ru) 2000-04-24
EA199900822A3 (ru) 2000-08-28
IL152924A (en) 2004-02-19
YU48999A (sh) 2002-06-19
IL152926A (en) 2004-02-19
PT994115E (pt) 2005-06-30
HRP990318A2 (en) 2000-06-30
CN1207295C (zh) 2005-06-22
PL335959A1 (en) 2000-04-25
ATE290003T1 (de) 2005-03-15
KR100380954B1 (ko) 2003-04-21
IL152927A0 (en) 2003-06-24
TW589314B (en) 2004-06-01
AP1233A (en) 2003-12-18
EE9900507A (et) 2000-06-15
EP0994115A2 (en) 2000-04-19
BR9905092A (pt) 2000-08-08
KR20000028987A (ko) 2000-05-25
UY25750A1 (es) 2001-08-27
NO313700B1 (no) 2002-11-18
TR199902541A2 (xx) 2000-07-21
DK0994115T3 (da) 2005-06-20
JP2000119273A (ja) 2000-04-25
CR6118A (es) 2005-09-16
EE04192B1 (et) 2003-12-15
AR019244A1 (es) 2001-12-26
AP9901672A0 (en) 1999-12-31
CN1473831A (zh) 2004-02-11
RS49762B (sr) 2008-04-04
CO5150214A1 (es) 2002-04-29
CZ296816B6 (cs) 2006-06-14
GEP20022700B (en) 2002-05-27
IS1951B (is) 2004-10-13
IL152928A (en) 2007-07-04
AU5358199A (en) 2000-04-13
HU226162B1 (en) 2008-05-28
GB9822238D0 (en) 1998-12-09
MY124620A (en) 2006-06-30
CA2285733C (en) 2004-08-24
ES2237049T3 (es) 2005-07-16
MA25007A1 (fr) 2000-07-01
IL152924A0 (en) 2003-06-24
DE69923906T2 (de) 2006-04-06
CZ353299A3 (cs) 2000-05-17
BG63205B1 (bg) 2001-06-29
UA66787C2 (en) 2004-06-15
IL152923A0 (en) 2003-06-24
JP3721021B2 (ja) 2005-11-30
NO994943D0 (no) 1999-10-11
US20030069422A1 (en) 2003-04-10
SK285215B6 (sk) 2006-09-07
IL132273A (en) 2004-06-20
BG103794A (en) 2000-09-29
SI0994115T1 (es) 2005-08-31
CA2285733A1 (en) 2000-04-12
PE20001086A1 (es) 2000-10-18
HUP9903469A3 (en) 2000-10-30
HK1027559A1 (en) 2001-01-19
EG22630A (en) 2003-05-31

Similar Documents

Publication Publication Date Title
CU22928A3 (es) Procedimiento para la preparación de pirazolo (4,3-d) pirimidin-7-onas y sus intermedios
CO4780028A1 (es) Procedimiento para la preparacion de sildenafil
UY23787A1 (es) Procedimiento para la preparacion de compuestos que contienen un anillo biciclico fusionado
HRP20000469B1 (en) Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
CO4960662A1 (es) Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados
DOP2001000200A (es) Compuestos de pirrolo [2,3-d] pirimidina
CO5560574A2 (es) Procesos para la preparacion de compuestos de aminopirimidina, halogenopirimidina, sulfoniloxipirimidina e hidroxipirimidina; y un compuesto de hidroxipirimidina
CO4900054A1 (es) Pirroles sustituidos
ES2191109T3 (es) Inhibidores de proteasas de guanidino.
BR0103072A (pt) Processo para a preparação de compostos de pirazolo[4,3-d] pirimidin-7-ona e seus intermediários
AR028743A1 (es) DERIVADOS DE N-TRIAZOLILMETIL-PIPERAZINA CON ACCIoN ANTAGONISTA DE RECEPTORES DE NEUROQUININA
AR042404A2 (es) Compuestos derivados de anilina
PA8519801A1 (es) Nuevo procedimiento para la preparacion de pirazolopirimidinonas
ECSP993154A (es) PROCEDIMIENTO PARA LA PREPARACION DE PIRAZOLO (4,3,d) -PIRIMIDIN -7-ONAS Y SUS INTERMEDIOS
BR0212153A (pt) Compostos e respectivos processos de preparação e de isolamento de dicloreto de 2-difluormetilornitina
BR0004787A (pt) Processo para a preparação de compostos pirazolo[4,3-d] pirimidin-7-onas-3-piridilsulfonila bem como intermediários dos mesmos
CO5540298A2 (es) Proceso para preparar un ligando de ppar de tiazol y polimorfos del mismo
HN1999000172A (es) Procedimiento para la preparacion de pirazolo (4,3-d) pirimidin-7-onas y sus intermedios
ES2170933T3 (es) Derivados de 4-vinil-4'-alfa-hidroximetil-bifenilo.
DE69827614D1 (de) Chinoxalindionen
IL136739A (en) Diol compounds and processes for their preparation
EA200201076A1 (ru) Терапевтически полезные новые соли ингибиторов хцк, способы их получения и фармацевтические препараты, содержащие их
SE0101323D0 (sv) New process
BR0315508A (pt) Processo para preparação de compostos de pirazol
ES2161602B1 (es) Sintesis de 6-(d-alfa-(bencilidenaminofenilacetamido))penicilanato de 1,1-dioxopenicilanoiloximetilo y analogos. nuevos intermedios para la sintesis de sultamicilina.